Haloperidol GPO

Haloperidol GPO

haloperidol

Manufacturer:

GPO

Distributor:

GPO
Concise Prescribing Info
Contents
Haloperidol
Indications/Uses
Schizophrenia, psychosis w/ agitation, drug-induced psychosis, aggressive disorders in childn, abnormal muscle contraction & stuttering in Tourette's syndrome, nausea & vomiting due to anticancer agents.
Dosage/Direction for Use
Adult Initially 0.5-5 mg bid-tid & increase gradually. Childn 3-12 yr Initially 0.05 mg/kg divided into 2-3 doses daily. May be increased in 0.5 mg increments every 5-7 days. Max: 0.15 mg/kg. Elderly Initially 0.5-2 mg/kg divided into 2-3 doses daily & may be increased gradually until reaching the optimal dose.
Administration
May be taken with or without food: May be taken w/ meals to minimise GI irritation.
Contraindications
Patients w/ CNS depression, coma or Parkinsonism.
Special Precautions
Long-term use may lead to addiction. Patients w/ CV disease, epilepsy, hyperthyroidism, history of drug allergy. Avoid exposure to sunlight or apply sunscreen to prevent photosensitivity during therapy. Driving or operating machinery is not recommended during therapy. Pregnancy & lactation. Childn <3 yr.
Adverse Reactions
Extrapyramidal symptoms eg, bradykinesia, slurred speech, muscle rigidity, tremor, ataxia; blurred vision; constipation, dry mouth, abnormal menstruation, breast engorgement w/ pain, galactorrhea, wt gain, abnormal blood profile, hypotension, jaundice, hyperthermia, photosensitivity.
Drug Interactions
Alcohol consumption, CNS depressants, antiepileptic drugs, levodopa, lithium, drugs causing extrapyrimidal symptoms.
MIMS Class
ATC Classification
N05AD01 - haloperidol ; Belongs to the class of butyrophenone derivatives antipsychotics.
Presentation/Packing
Form
Haloperidol GPO tab 5 mg
Packing/Price
1000's
Form
Haloperidol GPO tab 2 mg
Packing/Price
1000's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in